New blood clot drug tested in healthy volunteers – no cure yet

This early-stage study tested a new drug called Vitalangio1 in 627 healthy adults aged 18–55 to see if it is safe and how the body processes it. Participants took either the drug or a placebo, and some took it with or without food to see how that affects absorption. The study does not aim to treat or cure any disease, but to gather important safety and drug behavior information for future research.